RaQualia Pharma Inc.
4579.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥14 | ¥13 | ¥8 | ¥8 |
| - Cash | ¥4 | ¥3 | ¥3 | ¥3 |
| + Debt | ¥3 | ¥3 | ¥3 | ¥4 |
| Enterprise Value | ¥14 | ¥12 | ¥9 | ¥9 |
| Revenue | ¥1 | ¥1 | ¥1 | ¥1 |
| % Growth | 35.8% | -40.9% | 30.8% | – |
| Gross Profit | ¥1 | ¥0 | ¥1 | ¥1 |
| % Margin | 70.8% | 58.8% | 69.7% | 69% |
| EBITDA | ¥0 | -¥0 | ¥0 | ¥0 |
| % Margin | 0.1% | -32.4% | 16.8% | 0.7% |
| Net Income | -¥0 | -¥0 | -¥0 | -¥0 |
| % Margin | -27.6% | -61.3% | -0.5% | -21% |
| EPS Diluted | -8.76 | -15.25 | -0.24 | -7.16 |
| % Growth | 42.6% | -6,254.2% | 96.6% | – |
| Operating Cash Flow | ¥0 | ¥0 | -¥0 | -¥0 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | ¥0 |
| Free Cash Flow | ¥0 | ¥0 | -¥0 | -¥0 |